After a painful odyssey of more than 20 months, the one thing all Americans can agree on is that the CORONAVIRUS-19 pandemic has disrupted every facet of life. Everything from the global supply chain to the educational system have been forced to adapt.
It’s great to see the continued momentum in the state’s quest to get all Alabamian’s vaccinated. As COVID-19 vaccine availability expands to include more age groups, providers are naturally going to get more questions about the vaccine, potential side effects, interactions, etc. The Risk Consultants at Inspirien Insurance Company have compiled a list of 10 frequently asked questions regarding the vaccine to expedite clinical visits and support clinicians in their quest to combat COVID-19. These FAQ’s were obtained from evidenced based sites such as the CDC, The American Medical Association, and The New England Journal of Medicine.
According to Dr. Carlos del Rio, a Global Health Expert at Emory University “there is no contraindication in my mind to take the COVID-19 vaccine.” Dr. Rio goes on to note that clinical trials did not include those individuals in an immune-compromised state, so the efficacy of the vaccine is still unknown and may not be the same as an individual who is not in an immuno-compromised state. Patients are advised to not take the vaccination if they have had an allergic reaction to the vaccine or any component of the vaccine.
Currently, Alabama ranks toward the bottom in the country in regard to the number of citizens receiving the vaccine on a per capita basis. Why does Alabama seem to be trailing behind the rest of the country in vaccination rates?
State Health Officer is a difficult role to fill, especially this year. While partisanship and conspiracies continue to divide us, it is the job of the State Health Officer to make decisions for the good of all people throughout Alabama. This is exactly what Dr. Scott Harris has done for Alabamians during (and before) the COVID-19 pandemic.
The U.S. Department of Health and Human Services (HHS) has announced $20 billion in new funding for providers related to the coronavirus pandemic. Under this Phase 3 General Distribution allocation, providers that have already received Provider Relief Fund payments are eligible to apply for additional funding that considers financial losses and changes in operating expenses caused by the coronavirus. Previously ineligible providers, such as those who began practicing in 2020 will also be allowed to apply, and an expanded group of behavioral health providers confronting the emergence of increased mental health and substance use issues exacerbated by the pandemic will also be eligible for relief payments.
Eric Wallace, M.D., the medical director of UAB eMedicine, and Curt Carver Jr., Ph.D., vice president for Information Technology, both at the University of Alabama at Birmingham, were appointed by Governor Kay Ivey to serve on the Broadband Working Group to provide input and guidance on how to allocate funding from the federal Coronavirus Aid, Relief and Economic Security Act.
There is still a great deal of uncertainty regarding the coronavirus. Although researchers are studying several pharmaceuticals that may have positive effects on the virus, we still don’t have a definitive antidote. This is why it is important to do what we can to flatten the curve, and social distancing is one of the most effective remedies. This limits the spread of germs between people so that fewer people become sick and it buys our nation time to strengthen our healthcare forces.
The COVID-19 pandemic has challenged virtually every aspect of life, and for many of us, sleep has been severely affected.
On March 19, the Alabama Department of Public Health (ADPH) issued mandatory health orders to medical practices statewide to delay all elective medical and dental procedures until April 6th. On March 28, the order was amended such that non-emergency procedures are postponed further notice. Under these guidelines, Medical and dental practices have had to reduce office hours and/or close their office.
On Dec. 31, 2019, an outbreak of novel coronavirus (2019-nCoV) was first reported from Wuhan, China. Since then, the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and every major news outlet have kept us up to date on the outbreak and its impact across the world.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: